About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Role of PCSK9 Inhibitors in Diabetes
By
Stephen Kopecky
2 Videos
20,209 views
September 22, 2016
12 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
28:13
National Lipid Association
New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…
Feat.
R. Mason
59:01
The North American Thrombosis Forum (NATF)
Recent Cholesterol Guidelines and Integration into Clinical Practice
Feat.
J. Plutzky,
L. Braun,
J. Ross
08:44
AHA 2022 Conference Coverage
AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…
Feat.
N. Marston
14:50
AHA 2022 Conference Coverage
AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…
Feat.
K. Ray
21:27
Scripps Health
Lipids Update: Current Guidelines for Lipid Management
Feat.
S. R. Mehta
18:43
Canadian Collaborative Research Network
Lp(a): When to Measure it and What to Do About it
Feat.
M. O'Donoghue
45:45
Houston Methodist DeBakey Heart and Vascular Center
Directions of Cardiology in the Next Decade: 2022-2032
Feat.
E. Braunwald
26:32
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
Feat.
S. Nissen
31:02
Scripps Health
How Do I Reverse Coronary Plaque?
Feat.
C. J. Suhar
19:48
ACC 2022 Conference Coverage
ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…
Feat.
R. Giugliano
39:44
The Texas Heart Institute
Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…
Feat.
S. Virani
24:02
Complex Coronary Cases
Updated Lipid Guidelines and Therapy
Feat.
I. Fergus
33:43
Jefferson Health
Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk
Feat.
A. Cohen
22:14
Practical Ways to Achieve Targets in Diabetes Care
Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target
Feat.
S. Nissen
21:10
National Lipid Association
Plant-based Diets for Improving Lipids
Feat.
K. Williams
19:20
National Lipid Association
Colchicine: Now and What’s Next?
Feat.
C. Ballantyne
25:02
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
How to Reduce Cholesterol and Triglycerides to Prevent CV Events
Feat.
P. Taub
27:12
Norman Lepor
Update on Lipoprotein A: The Horrible Cholesterol
06:48
Complex Coronary Cases
LIVE Round Table: Panel Discussion on Lipid Management
Feat.
R. Mehran
31:50
Nadir Ali
Do Statins Prevent or Cause Heart Disease? Should LDL Be Called &quo…